Uveal Melanoma Biology, Biomarkers for Metastatic Risk and Personalized Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: closed (24 February 2024) | Viewed by 5859
Special Issue Editors
Interests: uveal melanoma; retinal capillary hemangioblastoma; Barrett esophagus and esophageal cancer; translational genetics; metabolomics; transcriptomics
Special Issues, Collections and Topics in MDPI journals
Interests: uveal melanoma; microRNA; genetics; prognostication; ctDNA; CTC
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There has been tremendous progress in knowledge regarding the (epi-)genomic and transcriptomic signatures of primary uveal melanoma. We can now profile these tumors up to a single cell level and provide detailed biomarker signatures. Using clinical information alongside these signatures, we can accurately classify tumors and can estimate prognosis in the range of low, mid, and high risk. We are now in the unique position of being able to explore individual patients’ germline DNA and tumor biology and provide a more detailed individual risk prediction, as well as evaluate and predict response to treatment options. Additionally, we can use this knowledge to improve our understanding of the processes behind metastasis and, for instance, develop noninvasive monitoring programs. In this Special Issue, experts in the field will contribute their science and insights into the biological mechanisms behind uveal melanoma metastasis, in vitro and in vivo experiments to elucidate uveal melanoma biology, signaling cascades to target using various interventions, and the uveal melanoma microenvironment and methods to accurately predict individual risk and treatment strategies.
Dr. Erwin Brosens
Dr. Emine Kilic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- uveal melanoma
- biomarkers
- treatment
- prognosis
- metastasis
- biological mechanisms
- personalized medicine
- molecular genetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.